既往腹部手术后机器人肝切除的安全性与可行性
本研究基于前瞻性上市后观察研究(DRKS00017229),分析2018年4月至2020年12月单中心126例机器人肝切除患者,其中59%有腹部手术史。结果显示既往手术组与无手术组在手术时间(258分钟)、中转率(6%)和严重并发症率(21% Clavien-Dindo≥3)上无差异,提示机器人肝切除对有腹部手术史者安全可行。
要点
- 既往腹部手术并非机器人肝切除的禁忌证。
- 有手术史与无手术史患者的手术时间、中转率和严重并发症率无差异。
- 既往肝切除史者手术时间延长仅见于单变量分析,多变量未证实。
核心结论
- 机器人肝切除在既往有腹部手术史的患者中安全可行。
- 应不考虑既往手术史,对每位患者评估微创手术可能性。
研究设计与样本
- 前瞻性上市后观察研究(DRKS00017229),单中心连续病例分析。
- 纳入2018年4月至2020年12月共126例机器人肝切除患者,使用da Vinci Xi系统。
主要发现
- 59%患者有腹部手术史,最常见为结直肠切除(28%)和肝切除(20%)。
- 无手术史患者更可能因肝细胞癌或良性肿瘤行机器人肝切除,且更常合并肝硬化。
- 手术时间258分钟、中转率6%、严重并发症率21%(Clavien-Dindo≥3)在两组间无差异。
- 既往肝切除史者手术时间延长仅见于单变量分析,多变量分析未证实。
关键数值与推荐
- 多变量分析显示肿瘤类型和肝硬化与手术时间独立相关。
临床怎么用
- 既往腹部手术史不应作为选择开腹肝切除的理由。
- 对有腹部手术史的患者,可考虑机器人肝切除。
局限性
- 单中心研究,样本量有限。
- 观察性研究设计可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While minimally invasive liver surgery has been increasingly adopted at least for minor resections, experience with robotic liver surgery is still limited to a few highly specialized centers. Due to the fear of abdominal adhesions, a history of prior surgeries is still used as an argument for open approaches. METHODS: Clinical data of all consecutive robotic resections at our center, using the da Vinci Xi surgical system, between April, 2018 and December, 2020, were collected and analyzed as part of a prospective, post-marketing observational study (DRKS00017229). Prior abdominal surgeries were specified according to the surgical approach and localization. Baseline and perioperative outcome criteria were compared between patients with prior surgeries (PS) and patients with no prior surgeries (NPS) in univariate and multivariate analyses. RESULTS: Out of the 126 patients undergoing robotic liver resections, 59% had a history of abdominal surgeries, which were most often colorectal resections (28%) followed by liver resections (20%). Patients with NPS were more likely to undergo robotic liver resection for hepatocellular carcinoma or benign tumors, and to have underlying liver cirrhosis when compared to patients with PS. Other baseline characteristics as well as the extent of resections were similar. Duration of surgery (258 min), conversion rates (6%), and postoperative complications rates (21% Clavien-Dindo ≥ 3) showed no differences between NPS and PS. A subgroup of patients with a history of prior liver surgery showed a longer duration of surgery in univariate analysis. However, this was not confirmed in multivariate analysis which instead revealed tumor entity and liver cirrhosis as independently correlated with duration of surgery. CONCLUSIONS: We propose robotic liver resection to be safe and feasible, including in patients with prior abdominal surgeries. Each patient should be evaluated for a minimally invasive procedure regardless of a history of previous operations.
引用
- Feldbrügge L, Ortiz Galindo SA, Frisch O, et al. Safety and feasibility of robotic liver resection after previous abdominal surgeries. Surg Endosc. 2021. PMID: 34076760. doi:10.1007/s00464-021-08572-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。